Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
95.00
+4.00 (4.40%)
At close: Jul 6, 2026
-27.06% (1Y)
| Market Cap | 646.74M -30.0% |
| Revenue (ttm) | 3.64B +14.3% |
| Net Income | 71.83M +76.8% |
| EPS | 10.55 +76.8% |
| Shares Out | 6.81M |
| PE Ratio | 9.00 |
| Forward PE | n/a |
| Dividend | 0.60 (0.66%) |
| Ex-Dividend Date | Sep 1, 2025 |
| Volume | 2,400 |
| Open | 91.05 |
| Previous Close | 91.00 |
| Day's Range | 91.05 - 95.00 |
| 52-Week Range | 74.30 - 143.55 |
| Beta | 0.60 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |